blindness from semaglutide Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden vision loss known as non-arteritic anterior ischemic A new study suggests patients

Routine consultation with your healthcare provider is appropriate when: Taste changes lead to significant unintentional weight loss beyond treatment goals Nutritional intake becomes severely restricted, raising concerns about deficiencies Taste alterations persist beyond 8-12 weeks without improvement Quality of life is substantially impacted by food aversions or taste disturbances New or worsening symptoms develop, such as persistent metallic taste with other concerning features Your provider can assess whether taste changes represent expected treatment effects or require investigation for alternative causes

Die Telefonnummer finden Sie auf unserer Visitenkarte

Support for people whose cognition is impaired by anxiety

J Am Osteopath Assoc

Effect of postmenopausal hormone therapy on lipoprotein(a) concentration